序号 |
标题 |
次数 |
作者 |
发布时间 |
73621 |
DNP-PEG1-CH2 acid的分子结构,1522301-61-6 |
93 |
wyh |
2024-12-24 |
73622 |
5,10,15,20-四(4-甲氧基-3-磺酸苯基)卟啉[T(4-MOP)PS4] |
160 |
WYQ |
2024-12-24 |
73623 |
Phe-Lys(Fmoc)-PAB ,抗体- 药物偶联物 |
154 |
hyy |
2024-12-24 |
73624 |
3,3'-二(3,4-二羧基苯氧基)-4,4'-二苯乙炔基联苯二酐(BPEBPDA) |
92 |
WYQ |
2024-12-24 |
73625 |
mPEG9-OCH2CH2COONHS Ester的介绍 |
92 |
zyl |
2024-12-24 |
73626 |
Ald-benzoylamide-PEG3-CH2 acid的主要功能与应用,1007215-91-9 |
86 |
wyh |
2024-12-24 |
73627 |
多孔卟啉基超支化聚酰亚胺(PPBPI-1-CR、PPBPI-2-CR) |
156 |
WYQ |
2024-12-24 |
73628 |
mPEG4-OCH2CH2COONHS Ester cas:874208-94-3 |
96 |
zyl |
2024-12-24 |
73629 |
Boc-Arg(di-Z)-OHVal-Cit-PAB-Eribulin,CAS: 2130869-21-3 |
91 |
h |
2024-12-24 |
73630 |
5,10,15,20-四[4-[(3-氨基苯基)乙炔基]苯基]卟啉(TAPEPP) |
150 |
WYQ |
2024-12-24 |
73631 |
Boc-Arg(di-Z)-OH,Boc-2-Z-L-精氨酸,CAS号:51219-19-3 |
81 |
h |
2024-12-24 |
73632 |
HO-PEG45-DAG的介绍 |
160 |
zyl |
2024-12-24 |
73633 |
Val-Cit-PAB-OH,ADC试剂,159857-79-1 |
153 |
hyy |
2024-12-24 |
73634 |
5,10-二(4-氨基苯基)-15,20-二苯基卟啉(Cis-DADPPH2) |
105 |
WYQ |
2024-12-24 |
73635 |
维甲酸甘草黄酮脂质体,Retinoic Acid-Glycyrrhizic Flavone Liposome |
136 |
axc |
2024-12-24 |
73636 |
BOC保护的丙氨酸锌卟啉(Zn·TAPP-Ala-BOC) |
98 |
WYQ |
2024-12-24 |
73637 |
Pebac; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone; D-Phe-Pro-Arg-CH2Cl |
77 |
h |
2024-12-24 |
73638 |
Phthalamidoxy-PEG1-CH2-ald的主要特点与功能 |
89 |
wyh |
2024-12-24 |
73639 |
HO-PEG36-DSG的介绍 |
78 |
zyl |
2024-12-24 |
73640 |
PPACK dihydrochloride,CAS号:142036-63-3,D-苯丙氨酸-脯氨酸-精氨酸-氯甲酮盐酸盐 |
138 |
h |
2024-12-24 |
73641 |
维甲酸脂质体,Retinoic Acid Liposome |
84 |
axc |
2024-12-24 |
73642 |
N-Phthaloyl-β-alanine,3-邻二甲酰亚氨基丙酸,CAS号:3339-73-9 |
92 |
h |
2024-12-24 |
73643 |
Ac-VLPE-FMK,CAS号:2679825-27-3 |
72 |
h |
2024-12-24 |
73644 |
DSG-PEG44-CH2CH2NH2的化学性质 |
92 |
zyl |
2024-12-24 |
73645 |
(S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH |
71 |
h |
2024-12-24 |
73646 |
伊立替康脂质体,Irinotecan Liposome |
220 |
axc |
2024-12-24 |
73647 |
Mal-NH-PEG7-COOH; Maleimide-NH-PEG7-CH2CH2COOH |
170 |
h |
2024-12-24 |
73648 |
Mal-amido-PEG7-acid,CAS号:2112731-42-5 |
76 |
h |
2024-12-24 |
73649 |
前列地尔脂质体,Alprostadil Liposome |
113 |
axc |
2024-12-24 |
73650 |
DSG-PEG45-OMe的介绍 |
93 |
zyl |
2024-12-24 |
73651 |
H2N-PEG27-CH2CH2NH2 |
81 |
h |
2024-12-24 |
73652 |
5,10-(2,2'-(1,2-乙二氧基)二-5-叔丁基苯基)-15,20-(2,2'-(1,2-乙二氧基)二-5-叔丁基苯基)卟啉1-Zn |
131 |
WYQ |
2024-12-24 |
73653 |
Amino-PEG27-amine,CAS号:2252208-09-4 |
97 |
h |
2024-12-24 |
73654 |
米托蒽醌脂质体,Mitoxantrone Liposome |
185 |
axc |
2024-12-24 |
73655 |
DMG-PEG24 二肉豆蔻酰-二十四聚乙二醇 |
76 |
zyl |
2024-12-24 |
73656 |
H2N-PEG15-CH2CH2NH2 |
61 |
h |
2024-12-24 |
73657 |
DSPE-PEG36-NH2 磷脂-三十六聚乙二醇-氨基 |
79 |
zyl |
2024-12-24 |
73658 |
Amino-PEG15-amine |
76 |
h |
2024-12-24 |
73659 |
5,10,15,20-四(五氟苯基)卟啉(TF5PPH2) |
114 |
WYQ |
2024-12-24 |
73660 |
Amino-PEG12-amine,CAS号:361543-12-6 |
63 |
h |
2024-12-24 |
73661 |
mPEG6-OCH2CH2COO-Naltrexone的结构式 |
98 |
zyl |
2024-12-24 |
73662 |
Mal-PEG2-CH2COOH的结构特点,173323-23-4 |
123 |
wyh |
2024-12-24 |
73663 |
H2N-PEG13-CH2CH2NH2,CAS号:1228119-65-0 |
98 |
h |
2024-12-24 |
73664 |
7-5-(4-硝基苯基)-10, 15, 20-三苯基镁卟啉(MgTPPNO2) |
91 |
WYQ |
2024-12-24 |
73665 |
Amino-PEG13-amine,CAS号:1228119-65-0 |
76 |
h |
2024-12-24 |